Category Archives: US Pressure

Access to affordable stents and other medical devices – Indian Government should reject the bullying tactics of the US based medical device industry

The US based medical devices industry through the Advanced Medical Technology Association (AdvaMed) has approached the US Trade Representative (USTR) with a demand to partially or fully suspend or withdraw India’s benefits under the Generalized System of Preferences (GSP). This … Continue reading

Posted in Uncategorized, US Pressure, USTR | Leave a comment

US turns screws on India over patent laws

By Nayanima Basu, The Hindu BusinessLine  | JUNE 27, 2017 India’s Intellectual Property Rights (IPR) and patent law enforcement as well New Delhi’s decision to cap prices of medical devices remained a contentious issue with the US even during Prime Minister … Continue reading

Posted in IPR, Patent, Uncategorized, US Pressure | 1 Comment

Many issues on tap for Trump-Modi visit

Source: Politico | June 26, 2017 TRUMP’S CHANCE TO RESET THE INDIA TRADE RELATIONSHIP: Indian Prime Minister Narendra Modi is meeting with President Donald Trump at the White House today, where they are expected to broach a wide-range of issues, … Continue reading

Posted in IPR, Uncategorized, US Pressure | Leave a comment

The Trump Executive Order on drug prices: not what was promised nor needed, and contrary to US self interest

Source: Medium Emily Kopp has a big scoop for Kaiser Health News. She has obtained a six page document outlining the draft provisions or objectives of a proposed Presidential Executive Order (EO) on drug prices. She has shared some of … Continue reading

Posted in Compulsory Licensing, Data Exclusivity, Evergreening, IPR Enforcement, Special 301 report, Uncategorized, UNHLP report, US Pressure | Leave a comment

June 2017 Alert: Pressure on countries hiked by US on IP

The US government is stepping up on TRIPS plus pressure through bilateral forums based on a US law that passed under Obama to strengthen IPR enforcement and the 301 process. Countries targeted include India, Indonesia, China, Thailand, Ukraine in Asia … Continue reading

Posted in Compulsory Licensing, Data Exclusivity, Evergreening, IPR Enforcement, Special 301 report, Uncategorized, UNHLP report, US Pressure | Leave a comment